ITOC

iTonic Holdings Ltd.
NASDAQHEALTHCAREMEDICAL DEVICES

Key Statistics

Market Cap
$7.67M
P/E Ratio
EPS
$-0.32
Beta
52W High
$1.09
52W Low
$0.25
50-Day MA
$0.33
200-Day MA
$0.46
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About iTonic Holdings Ltd.

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)523,030
Gross Profit (TTM)327,350
EBITDA$-5.17M
Operating Margin-682.00%
Return on Equity-71.30%
Return on Assets-41.00%
Revenue/Share (TTM)$0.03
Book Value$0.36
Price-to-Book0.85
Price-to-Sales (TTM)14.66
EV/Revenue4.625
EV/EBITDA
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)91.60%
Shares Outstanding$9.38M
Float$15.64M
% Insiders1.82%
% Institutions0.10%

Historical Volatility

HV 10-Day
HV 20-Day
HV 30-Day
HV 60-Day
HV Rank

Latest News

iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule

BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the “Company” or “ITOC”), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced that on April 21, 2026, it received notification from The Nasdaq Stock Market LLC (“Nasdaq”) that Nasdaq approved the Company's request for an extension of additional 180-calendar day, or until October 19, 2026 (the “Extension”) to regain compliance with the minimum closing bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”).The Extension follows the expiration the initial 180-calendar day compliance period on April 20, 2026.

GlobeNewsWire4/23/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026